Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Outlook

Outlook

posted on Feb 22, 2007 09:29AM

Even with Dutton's conservative estimate of 1.12 sp within the next 12 mos. (with out dated info)

Investing now at .65 would give an investor +70%return over the next twelve months.                         Not a bad return...

 

Share
New Message
Please login to post a reply